NANOTECHNOLOGYA recent study found that nanoparticle vaccines enhance influenza cross-protection through cellular and mucosal immune responses. Learn about this breakthrough in vaccine technology.
The US government awards $176 million to Moderna to develop an mRNA influenza vaccine amid bird flu pandemic fears. Discover the potential impact of this initiative.
A new 2-in-1 vaccine against COVID-19 and flu has been shown to be superior to separate shots in late-stage trials. Continue reading the article to learn more.
Uncover the truth behind measles vaccine skepticism and other diseases. Explore four misleading claims and get the facts you need to stay informed. Read more!
Despite proven effectiveness in reducing cancer risk in men, HPV vaccine uptake among boys in the US remains low. Learn about the importance of vaccination for male health. Read more!
A new HIV vaccine triggered low levels of a rare type of neutralizing antibodies among a small group of people who participated in a 2019 clinical trial. Find out more about it in this article.
A recent vaccine analysis showed that the latest COVID-19 shots for adults is 54% effective against symptomatic cases. Read the article for more details.
Despite developing a COVID-19 vaccine within a year, HIV lacks one after 40 years, raising questions about the disparity. Check out this article to learn why there is still no HIV vaccine until today.
The FDA approves Ixchiq, the first chikungunya vaccine, addressing rising global cases and the spread of disease-carrying mosquitoes due to climate change. Read the article for more details.
The newly updated COVID-19 vaccines offer enhanced protection for individuals of all ages. Check out the top 10 things you need to know in this article.
Thanks to the scientists' COVID-19 mRNA vaccines, millions were saved, COVID-19 severity was hampered, the disease's general burden was reduced, and societies got to open once more. Read to learn more.